Gamma radiation emission

Gamma radiation emission is a physical phenomenon characterized by the release of high-energy electromagnetic radiation from an atomic nucleus during radioactive decay. Unlike biological receptors or enzymes, it is not a therapeutic target but a physical modality widely employed in oncology for radiotherapy and in diagnostic imaging through nuclear medicine. Gamma rays possess high penetrative power, allowing them to reach deep-seated tumors where they induce lethal DNA damage, particularly double-strand breaks, and trigger apoptosis in rapidly dividing malignant cells (IAEA, 2022). In clinical practice, gamma radiation is delivered either via external beam sources or through radiopharmaceuticals that localize to specific tissues. However, its ionizing nature is inherently non-selective, posing risks of significant toxicity to healthy tissues, which can lead to adverse effects such as radiation dermatitis, organ dysfunction, or the induction of secondary cancers later in life (NIH, 2023). Therapeutic strategies involving gamma radiation often include the use of radioprotectors like amifostine to mitigate damage to normal cells while maintaining the efficacy of the radiation against the tumor.

Other names

Gamma raysγ-raysIonizing electromagnetic radiationHigh-energy photon radiation

Gamma radiation causes biological damage through ionization, where high-energy photons displace electrons from atoms within cells. This process results in direct damage to the DNA backbone (double-strand breaks) or indirect damage through the radiolysis of water, which generates highly reactive free radicals that subsequently attack cellular components (National Cancer Institute, 2023).